Revagenix

Revagenix is a biopharmaceutical company dedicated to developing urgently needed anti-infective medicines to combat drug-resistant infections that lead to tens of thousands of deaths annually. By integrating a comprehensive understanding of the biopharmaceutical lifecycle, the company aims to innovate and commercialize life-changing antibiotics.

The Revagenix team is composed of experienced industry veterans who bring deep insights into the challenges and opportunities within the antibiotic development space. With a proprietary pipeline of differentiated antibiotic programs in late preclinical stages, Revagenix is focused on addressing the evolving landscape of anti-infectives.

Generated from the website